ROBERT DAUSER to Combined Modality Therapy
This is a "connection" page, showing publications ROBERT DAUSER has written about Combined Modality Therapy.
Connection Strength
0.050
-
Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine: safety profile and efficacy in the early postoperative period. Neurosurgery. 2010 Nov; 67(5):1195-204; discussion 1204.
Score: 0.017
-
A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET. Neuro Oncol. 2009 Feb; 11(1):33-40.
Score: 0.015
-
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 2006 Oct; 7(10):813-20.
Score: 0.013
-
Congenital mesoblastic nephroma metastatic to the brain. Cancer. 1993 Oct 15; 72(8):2499-502.
Score: 0.005